← Eichor
Study identifier: NCT06880094 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study of Congenital Orofacial Clefts by Implementing Optical Genome Mapping

Condition: Orofacial Clefts · Next Generation Sequencing (NGS) · Optical Genome Mapping  ·  Sponsor: Centre Hospitalier Universitaire, Amiens

PhaseNA
Planned participants26
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Orofacial clefts, the most common congenital craniofacial malformations, have a complex etiology involving an interaction between genetic and environmental factors. Chromosomal abnormalities, including structural variations, represent a major cause of human pathology. Recently, technological developments and the introduction of next-generation sequencing (NGS) technologies have revolutionized the field of medical genetics. Optical genome mapping (OGM) is an innovative, high-resolution "long read" technique that enables the identification of all classes of chromosomal variation, consisting in the direct visualization of long, labeled DNA molecules throughout the genome. This technology is gradually becoming an essential tool for studying onco-hematology and constitutional genetic pathologies The purpose of this study is to search for structural chromosomal variants (SV) or copy number variants (CNV) not identifiable either by cytogenetic methods nor by "short read" NGS "short read, in individuals with oral-facial clefts with no genetic diagnosis.

This description comes directly from the study's public registry record.

Talk to the study team

Bénédicte DEMEER, MD  ·  33+322087581  ·  Demeer.Benedicte@chu-amiens.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHRU AmiensAmiens, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06880094